Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 1
2008 2
2009 5
2010 5
2011 4
2012 1
2013 3
2014 2
2015 4
2016 5
2017 7
2018 8
2019 9
2020 8
2021 8
2022 10
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Review: Ewing Sarcoma Predisposition.
Gargallo P, Yáñez Y, Juan A, Segura V, Balaguer J, Torres B, Oltra S, Castel V, Cañete A. Gargallo P, et al. Among authors: canete a. Pathol Oncol Res. 2020 Oct;26(4):2057-2066. doi: 10.1007/s12253-019-00765-3. Epub 2019 Oct 26. Pathol Oncol Res. 2020. PMID: 31656020 Free article. Review.
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.
Botta L, Gatta G, Capocaccia R, Stiller C, Cañete A, Dal Maso L, Innos K, Mihor A, Erdmann F, Spix C, Lacour B, Marcos-Gragera R, Murray D, Rossi S; EUROCARE-6 Working Group. Botta L, et al. Among authors: canete a. Lancet Oncol. 2022 Dec;23(12):1525-1536. doi: 10.1016/S1470-2045(22)00637-4. Epub 2022 Nov 16. Lancet Oncol. 2022. PMID: 36400102
[Neuroblastoma].
Castel V, Cañete A, Noguera R, Navarro S, Oltra S; Grupo Español de Neuroblastoma (SEOP). Castel V, et al. Among authors: canete a. Clin Transl Oncol. 2005 Apr;7(3):133-45. doi: 10.1007/BF02708748. Clin Transl Oncol. 2005. PMID: 15899223 Review. Spanish. No abstract available.
Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.
Matser YAH, Verly IRN, van der Ham M, de Sain-van der Velden MGM, Verhoeven-Duif NM, Ash S, Cangemi G, Barco S, Popovic MB, van Kuilenburg ABP, Tytgat GAM; SIOPEN Catecholamine Working Group. Matser YAH, et al. Pediatr Blood Cancer. 2023 Jun;70(6):e30289. doi: 10.1002/pbc.30289. Epub 2023 Apr 3. Pediatr Blood Cancer. 2023. PMID: 37010353
Advances in emerging drugs for the treatment of neuroblastoma.
Berlanga P, Cañete A, Castel V. Berlanga P, et al. Among authors: canete a. Expert Opin Emerg Drugs. 2017 Mar;22(1):63-75. doi: 10.1080/14728214.2017.1294159. Epub 2017 Feb 22. Expert Opin Emerg Drugs. 2017. PMID: 28253830 Review.
Metabolomic profiling in neuroblastoma.
Quintás G, Yáñez Y, Gargallo P, Juan Ribelles A, Cañete A, Castel V, Segura V. Quintás G, et al. Among authors: canete a. Pediatr Blood Cancer. 2020 Mar;67(3):e28113. doi: 10.1002/pbc.28113. Epub 2019 Dec 4. Pediatr Blood Cancer. 2020. PMID: 31802629
Methodological advances in the discovery of novel neuroblastoma therapeutics.
Segura MF, Soriano A, Roma J, Piskareva O, Jiménez C, Boloix A, Fletcher JI, Haber M, Gray JC, Cerdá-Alberich L, Martínez de Las Heras B, Cañete A, Gallego S, Moreno L. Segura MF, et al. Among authors: canete a. Expert Opin Drug Discov. 2022 Feb;17(2):167-179. doi: 10.1080/17460441.2022.2002297. Epub 2021 Nov 22. Expert Opin Drug Discov. 2022. PMID: 34807782 Review.
87 results